09.12.2009 • News

Huntsman Posts Loss

Huntsman posted a wider-than-expected quarterly loss, hurt by decreased demand in all of its businesses. Net loss for the Q1 was $290 million compared with net income of $7 million a year earlier. Revenue fell 33 % to $1.69 billion and missed analysts' average forecast of $2.17 billion. Huntsman, which recently terminated a $6.5 billion pact to be acquired by Apollo Management's Hexion Specialty Chemicals, said it intends to reduce its full-time workforce by about 1,250 positions, or nearly 10 %.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.